Clinical Trial

Measuring Cell-Free DNA (cfDNA) Levels in People With Follicular Lymphoma

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The researchers are doing this study to measure and test cell-free DNA (cfDNA) in the blood before, during, and after first-line treatment for follicular lymphoma. They will look at whether cfDNA levels are related to a person's response to the usual first-line treatment for follicular lymphoma. Researchers also want to understand how different genetic changes in follicular lymphoma relate to a person's response to the usual first-line treatment.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-07 -> 2027-07 2026-08-13
minor Completion pushed: 2026-07 -> 2027-07 2026-08-13
Trial Details
NCT Number NCT04468841
Lead Sponsor Memorial Sloan Kettering Cancer Center
Conditions Follicular Lymphoma
Enrollment 77 participants
Start Date 2020-07-08
Primary Completion 2027-07 (estimated)
Study Completion 2027-07 (estimated)
Updated on ClinicalTrials.gov 2026-08-12